| Mrs Theresa Eileen Deveaux, CRNP | |
|
301 Hospital Dr, Glen Burnie, MD 21061-5803 | |
| (410) 553-8300 | |
| (410) 553-8349 |
| Full Name | Mrs Theresa Eileen Deveaux |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Acute Care |
| Location | 301 Hospital Dr, Glen Burnie, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013919067 | NPI | - | NPPES |
| F591 0008 | Other | DC | CAREFIRST BLUE CROSS DC |
| 4992 | Other | MD | BRAVO/ELDER HEALTH |
| 61740701 | Other | MD | CAREFIRST BLUE CROSS MD |
| 400067600 | Medicaid | MD | |
| 107423 | Other | MD | AMERIGROUP |
| 22500900 | Other | MD | CIGNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | R093166 (Maryland) | Primary |
| Entity Name | University Of Maryland Community Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477530624 PECOS PAC ID: 3678472214 Enrollment ID: O20040102000687 |
News Archive
The Singapore Immunology Network (SIgN), an institute of the Agency of Science, Technology and Research (A*STAR), and VIVALIS, a French biopharmaceutical company, announced today the discovery of two new fully human monoclonal antibodies which could battle Chikungunya, a disease that currently has no available vaccine or specific treatment.
Dr Slater and colleagues (University College London, UK) studied the association between cortical pain responses in young infants and currently used pain assessment tools which are based on behavioural and physiological measures, such as change in facial expression.
Results of a large national study show that nearly three-quarters of obese patients with type 2 diabetes who undergo weight-loss surgery are able to stop insulin and other antidiabetes drugs within six months. In the Johns Hopkins study of insured, obese, diabetic patients, researchers also found that in the third year following surgery, average annual health care costs per patient decreased by more than 70 percent. The study is published in the Archives of Surgery this month.
Schering-Plough Corporation has announced that Schering-Plough K.K., the company's subsidiary in Japan, has submitted a New Drug Application (J-NDA) to the Ministry of Health, Labor and Welfare (MHLW) seeking marketing approval for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection for use in combination with REBETOL(R) (ribavirin) Capsules for the treatment of chronic hepatitis C.
Tetraphase Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration has granted Fast Track designations for both the intravenous (IV) and oral formulations of the company's lead antibiotic candidate, eravacycline.
› Verified 6 days ago
| Entity Name | Baltimore Washington Medical Center Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124016696 PECOS PAC ID: 7719879485 Enrollment ID: O20040326001160 |
News Archive
The Singapore Immunology Network (SIgN), an institute of the Agency of Science, Technology and Research (A*STAR), and VIVALIS, a French biopharmaceutical company, announced today the discovery of two new fully human monoclonal antibodies which could battle Chikungunya, a disease that currently has no available vaccine or specific treatment.
Dr Slater and colleagues (University College London, UK) studied the association between cortical pain responses in young infants and currently used pain assessment tools which are based on behavioural and physiological measures, such as change in facial expression.
Results of a large national study show that nearly three-quarters of obese patients with type 2 diabetes who undergo weight-loss surgery are able to stop insulin and other antidiabetes drugs within six months. In the Johns Hopkins study of insured, obese, diabetic patients, researchers also found that in the third year following surgery, average annual health care costs per patient decreased by more than 70 percent. The study is published in the Archives of Surgery this month.
Schering-Plough Corporation has announced that Schering-Plough K.K., the company's subsidiary in Japan, has submitted a New Drug Application (J-NDA) to the Ministry of Health, Labor and Welfare (MHLW) seeking marketing approval for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection for use in combination with REBETOL(R) (ribavirin) Capsules for the treatment of chronic hepatitis C.
Tetraphase Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration has granted Fast Track designations for both the intravenous (IV) and oral formulations of the company's lead antibiotic candidate, eravacycline.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Theresa Eileen Deveaux, CRNP 301 Hospital Drive, Glen Burnie, MD 21061 Ph: (410) 553-8300 | Mrs Theresa Eileen Deveaux, CRNP 301 Hospital Dr, Glen Burnie, MD 21061-5803 Ph: (410) 553-8300 |
News Archive
The Singapore Immunology Network (SIgN), an institute of the Agency of Science, Technology and Research (A*STAR), and VIVALIS, a French biopharmaceutical company, announced today the discovery of two new fully human monoclonal antibodies which could battle Chikungunya, a disease that currently has no available vaccine or specific treatment.
Dr Slater and colleagues (University College London, UK) studied the association between cortical pain responses in young infants and currently used pain assessment tools which are based on behavioural and physiological measures, such as change in facial expression.
Results of a large national study show that nearly three-quarters of obese patients with type 2 diabetes who undergo weight-loss surgery are able to stop insulin and other antidiabetes drugs within six months. In the Johns Hopkins study of insured, obese, diabetic patients, researchers also found that in the third year following surgery, average annual health care costs per patient decreased by more than 70 percent. The study is published in the Archives of Surgery this month.
Schering-Plough Corporation has announced that Schering-Plough K.K., the company's subsidiary in Japan, has submitted a New Drug Application (J-NDA) to the Ministry of Health, Labor and Welfare (MHLW) seeking marketing approval for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection for use in combination with REBETOL(R) (ribavirin) Capsules for the treatment of chronic hepatitis C.
Tetraphase Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration has granted Fast Track designations for both the intravenous (IV) and oral formulations of the company's lead antibiotic candidate, eravacycline.
› Verified 6 days ago
Ms. Docia Owusu, CRNP-PMH Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7575 E Howard Rd, Glen Burnie, MD 21060 Phone: 410-768-8200 | |
Marlowe Ann Driscoll, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7671 Quarterfield Rd Ste 301, Glen Burnie, MD 21061 Phone: 855-527-7246 Fax: 866-229-5063 | |
Jesse Okonigbo, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 116 Warwickshire Ln, Apt E, Glen Burnie, MD 21061 Phone: 302-382-7248 | |
Ms. Linda Jean Swallow, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 305 Hospital Dr, 1st Floor, Glen Burnie, MD 21061 Phone: 410-552-8154 Fax: 410-553-8134 | |
Mary Bourbon, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1600 S. Cain Highway, Suite 401, Glen Burnie, MD 21061 Phone: 410-768-5050 | |
Christine Marie Habersaat, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1405 Madison Park Dr Ste 1, Glen Burnie, MD 21061 Phone: 410-582-9434 |